ReachMD, the voice of healthcare professionals, on XM Radio Channel 160, online at www.reachmd.com, and on the MedicalRadio iPhone app announced their newest original programming series: Sexual Medicine and Health– which commences on April 26th, 2010. This groundbreaking series is dedicated to providing healthcare professionals the latest advances and perspectives on the wide range of physical, psychological, and socio-cultural issues impacting sexual function and health for the estimated 30 – 45 percent of patients who may be suffering in this often overlooked area.
The new series is hosted by Dr. Maureen Whelihan, a board-certified OB/GYN who has practiced in West Palm Beach, Florida, since 1997. Dr. Whelihan is a founding partner in the Center for Sexual Health and Education, based in West Palm Beach and Charlotte, North Carolina. She is a board member for the International Society for the Study of Women's Sexual Health, the immediate past president of the Palm Beach County Medical Society, and the current president of the Florida Obstetric and Gynecologic Society.
"Our ReachMD medical editorial board is pleased to help provide information and education on this important topic," says Gary Epstein, CEO of ReachMD. "Healthcare professionals need to be fully informed in order to provide solutions to their patients who may otherwise be reluctant to address this sensitive medical issue."
To listen to the first program in the series go to - www.reachmd.com/sexmed.Sexual Medicine and Health is sponsored by Zestra® from Semprae Laboratories.
About ReachMD: ReachMD, headquartered in Chicago, Illinois, is a leading provider of advanced healthcare information and education for medical professionals, including CME. ReachMD's live stream and on-demand audio programming is delivered via XM satellite radio channel 160, www.reachmd.com, and the MedicalRadio iPhone app.
AboutZestra®: Zestra® Essential Arousal Oils is a safe, topically applied, patented blend of botanical oils and extracts, clinically proven to increase a woman's feelings of desire and arousal - with a 5 year history of successful clinical use by leading sexual health practitioners. Additionally, in two, placebo-controlled, peer-reviewed, published studies, Zestra®'s effect on desire, arousal and satisfaction was statistically significant versus placebo with 70% of women, regardless of age, life stage, or health situation, experiencing improvement with no serious adverse events. You can get more information about Zestra® from Semprae Laboratories by visiting www.zestra.com.
Contacts:
ReachMD
Matthew Schreiner, 847-205-9075